Announcement of TTY Biopharm's unaudited income information in June 2021
2021.7.12
Provided by: TTY BIOPHARM COMPANY LIMITED
| SEQ_NO | 1 | Date of announcement | 2021/07/12 | Time of announcement | 13:46:34 |
| Subject | Announcement of TTY Biopharm's unaudited income information in June 2021 | ||||
| Date of events | 2021/07/12 | To which item it meets | paragraph 53 | ||
| Statement | 1.Date of occurrence of the event:2021/07/12 2.Company name:TTY Biopharm Co., Ltd. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office 4.Reciprocal shareholding ratios:N/A 5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of $310,476 thousands (expressed in NT dollars; unaudited), a consolidated operating profit of $80,343 thousands, and a consolidated income before tax of $106,365 thousands in June 2021; net income attributed to stockholders of the parent company was $88,009 thousands; EPS is $0.35. Year-to-date consolidated net sales was $2,007,025 thousands (in NT dollars; unaudited), a consolidated operating profit was $270,942 thousands and consolidated income before tax was $348,960 thousands until June 2021; year-to-date net income attributed to stockholders of the company was $238,587 thousands; EPS is $0.96. 6.Countermeasures:N/A 7.Any other matters that need to be specified: The numbers above are unaudited. In term of the final net sales and profits, quarterly financial reports audited by independent accountants will prevail. |
||||